Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 04, 2014 08:45 ET | Source: Context Matters

Context Matters to Participate in Webinar With Oracle Health Sciences and Tufts Center for the Study of Drug Development on Integration of Real-World Data in Drug Development Strategy

NEW YORK, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Context Matters announces that its CEO, Yin Ho, MD, MBA, will participate in a webinar sponsored by Oracle Health Sciences and Pharmaceutical...
January 22, 2014 09:15 ET | Source: Context Matters

Context Matters Launches the New Version of Its Reimbursement Risk Tracker Application, Featuring "Snapshots," a Dynamic, Never-Before-Seen View of the Reimbursement and Drug Development Landscape

NEW YORK, Jan. 22, 2014 (GLOBE NEWSWIRE) -- Context Matters announces the release of the new version of its flagship application, the Reimbursement Risk Tracker™ (RRT), featuring Snapshots. The...
July 01, 2013 09:00 ET | Source: Context Matters

Context Matters Makes Key Hires in Analytics and Technology

NEW YORK, July 1, 2013 (GLOBE NEWSWIRE) -- Context Matters announces two key hires to enhance its data, technology and analytics platform product. Kermit E. Daniel, Ph.D. assumes the role of Chief...
June 18, 2013 09:37 ET | Source: Context Matters

Context Matters Appoints Dr. Paul Greenberg to Its Board of Advisors

NEW YORK, June 18, 2013 (GLOBE NEWSWIRE) -- Context Matters announces the addition of Dr. Paul Greenberg to its Board of Advisors. "The addition of Paul to our Board of Advisors brings significant...
May 30, 2013 09:35 ET | Source: Context Matters

Context Matters Introduces Solid Tumor Cancer Module Into Its Proprietary Reimbursement Risk Tracker(TM) at American Society of Clinical Oncology (ASCO) Conference

NEW YORK, May 30, 2013 (GLOBE NEWSWIRE) -- Context Matters announces the addition of a solid tumor cancer module into its proprietary thin-client, cloud-based web application and data platform, the...
May 21, 2013 09:30 ET | Source: Context Matters

New Studies Demonstrate General Agreement in Reimbursement Decisions and the Value of Interventional Outcomes, Regardless of Location

NEW YORK, May 21, 2013 (GLOBE NEWSWIRE) -- Context Matters presented two studies at ISPOR's 18th Annual International Meeting in New Orleans. The first, a presentation, demonstrated agreement by more...
May 20, 2013 09:30 ET | Source: Context Matters

Despite Rising Pharmaceutical Industry Interest in Real World Outcomes, Few Patient-Reported Outcomes Are Included in Diabetes Clinical Trials According to a Context Matters/Pfizer Study

NEW ORLEANS, May 20, 2013 (GLOBE NEWSWIRE) -- Despite rising interest in real world outcomes, a recent study performed by Context Matters and Pfizer demonstrates that less than ten percent of diabetes...
April 18, 2013 08:45 ET | Source: Context Matters

Context Matters to Demonstrate Flagship Product Reimbursement Risk Tracker at BIO Conference

NEW YORK, April 18, 2013 (GLOBE NEWSWIRE) -- Context Matters announces that it will be an exhibitor at the BIO Conference, where it will be demonstrating its Reimbursement Risk Tracker™, a...
April 08, 2013 08:35 ET | Source: Context Matters

Context Matters Introduces Real-World Evidence Into Its Proprietary Reimbursement Risk Tracker(TM)

NEW YORK, April 8, 2013 (GLOBE NEWSWIRE) -- Context Matters announces the addition of patient-reported outcomes (PROs) to its proprietary data platform, the Reimbursement Risk Tracker™, which...
November 06, 2012 09:30 ET | Source: Context Matters

Use of "Efficacy" and "Effectiveness" Often Misleading and May Skew Reimbursement Decisions

NEW YORK, Nov. 6, 2012 (GLOBE NEWSWIRE) -- A recent global analysis of product evaluations for Health Technology Assessments – which are often influential in decision making for approving and/or...